A Possible Link of Gut Microbiota Alteration in Type 2 Diabetes and Alzheimer’s Disease Pathogenicity: An Update
- 31 May 2014
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 13 (3) , 383-390
Abstract
Imbalances in gut microbiota are associated with metabolic disorder, which are a group of obesity-related metabolic abnormalities that increase an individual’s risk of developing type 2 diabetes (T2D) and Alzheimer’s disease (AD). Although a number of risk factors have been postulated that may trigger the development of AD, the root cause of this disease is still a matter of debate. This review further investigates the etiology of AD by accumulating the current role played by gut microbiota in human, and trying to establish an inter-link between T2D and AD pathogenesis. There is a growing body of evidence which suggests that obesity is associated with alteration in the normal gut flora, reduced bacterial diversity, metabolic pathways and altered representation of bacterial genes. Obesity and T2D are considered to be induced as a result of changes within the composition of gut microbiota. The evidence gathered so far clearly advocates the involvement of gut microbes in causing obesity, a state of chronic and low-grade inflammation. Hence, understanding the microbiota of the gut is significant in relation to inflammation, as it is a key contributor for diabetes which has a direct relation to the AD pathogenesis. Comparative analysis of gut microbiota may enable further novel insight into the complex biology of AD, which is very important in order to take preventive measure such as early diagnosis, identification of new therapeutic targets and development of novel drugs.Keywords
This publication has 59 references indexed in Scilit:
- Genetic Control of Obesity and Gut Microbiota Composition in Response to High-Fat, High-Sucrose Diet in MiceCell Metabolism, 2013
- Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cellsBiochemical and Biophysical Research Communications, 2011
- CXCL10 Impairs β Cell Function and Viability in Diabetes through TLR4 SignalingCell Metabolism, 2009
- Pathogenesis of type 2 diabetes: tracing the reverse route from cure to causeDiabetologia, 2008
- Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut MicrobiomeCell Host & Microbe, 2008
- C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat dietDiabetologia, 2007
- Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytesBiochemical and Biophysical Research Communications, 2006
- A dynamic partnership: Celebrating our gut floraAnaerobe, 2005
- Who controls the crowd? New findings and old questions about the intestinal microfloraImmunology Letters, 2005
- Antibiotic-associated diarrhoeaBest Practice & Research Clinical Gastroenterology, 2004